21 November 2002
Reversed circadian rhythms of heart rate variability and morning peak occurrence of sustained ventricular tachyarrhythmias in patients with implanted cardioverter defibrillator.
Roland Fries, Sandra Hein, Jochem KönigMed Sci Monit 2002; 8(11): CR751-756 :: ID: 4836
Abstract
BACKGROUND: It is generally supposed that diurnal fluctuations of heart rate variability (HRV) are associated with diurnal variability of occurrence of sudden cardiac death, usually caused by tachyarrhythmias. To date, however, there have been no data comparing circadian rhythms of HRV and circadian variability of malignant ventricular tachyarrhythmias in the same patients. MATERIAL/METHODS: We studied 20 consecutive recipients of implantable cardioverter defibrillators in long-term follow-up, comparing the circadian rhythms of HRV in patients with and without typical morning peak occurrence of ventricular tachyarrhythmias. RESULTS: The HRV marker of vagus activity (RMSSD and HF power) displayed physiological circadian variability (highest values during sleep time, morning dip) only in patients without morning peak of arrhythmic events, and inverse circadian variability in patients with tachyarrhythmic morning peak. The variations in LF power and LF/HF ratio in both groups were not statistically significant, but with respect to the time interval between midnight and noon again showed inverse diurnal variation in patients with and without morning peak of arrhythmic events. CONCLUSIONS: These data suggest an association between a reversed circadian rhythm of HRV and morning peak frequency of tachyarrhythmic events in patients with ICD. As pronounced adrenergic hyperactivity in heart failure is the probable reason for paradoxically reversed circadian HRV variation, this association supports the hypothesis that the morning peak frequency of cardiovascular events may be interpreted as a sign of cardiovascular overload by the natural change from sleep to activity after awakening.
Keywords: Tachycardia, Ventricular - therapy
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952